Shopping Cart 0
Cart Subtotal
USD 0

China Orthobiologics Market Outlook to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

China Orthobiologics Market Outlook to 2025

Summary

GlobalData's new report, China Orthobiologics Market Outlook to 2025, provides key market data on the China Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Orthobiologics market.

- Global corporate-level profiles of key companies operating within the China Orthobiologics market.

- Key players covered include Medtronic plc, Seikagaku Corp, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Orthobiologics Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Orthobiologics Market, China 7

3.1 Orthobiologics Market, China, Revenue (USDm), 2015-2025 7

3.2 Orthobiologics Market, China, Volume (Units), 2015-2025 17

3.3 Orthobiologics Market, China, Average Price (USD), 2015-2025 29

3.4 Orthobiologics Market, China, Distribution Share by Revenue (USDm), 2017 31

3.5 Orthobiologics Market, China, Company Share by Revenue (USDm), 2017 32

4 Overview of Key Companies in China, Orthobiologics Market 34

4.1 Seikagaku Corp 34

4.2 DePuy Synthes Inc 34

4.3 Stryker Corp 34

4.4 Medtronic Plc 34

4.5 Zimmer Biomet Holdings Inc 35

4.6 IGEA SpA 35

4.7 ConMed Corporation 35

4.8 Shandong Haiyou Freda Pharmacy Co Ltd 35

5 Orthobiologics Market Pipeline Products 36

6 Recent Developments 38

6.1 Corporate Communications 38

6.2 Financial Announcements 38

7 Appendix 40

7.1 Research Methodology 41

7.2 GlobalData Consulting 45

7.3 Contact Us 46

7.4 Disclaimer 46


List Of Figure

1.2 List of Figures

Figure 1: Orthobiologics Market, China, Revenue (USDm), USD Constant, 2015-2025 8

Figure 2: Bone Grafts and Substitutes Market, China, Revenue (USDm), USD Constant, 2015-2025 10

Figure 3: Bone Growth Stimulators Market, China, Revenue (USDm), USD Constant, 2015-2025 12

Figure 4: Soft Tissue Biologics Market, China, Revenue (USDm), USD Constant, 2015-2025 14

Figure 5: Viscosupplementation Market, China, Revenue (USDm), USD Constant, 2015-2025 16

Figure 6: Orthobiologics Market, China, Volume (Units), 2015-2025 18

Figure 7: Bone Grafts and Substitutes Market, China, Volume (Units), 2015-2025 21

Figure 8: Bone Growth Stimulators Market, China, Volume (Units), 2015-2025 24

Figure 9: Soft Tissue Biologics Market, China, Volume (Units), 2015-2025 26

Figure 10: Viscosupplementation Market, China, Volume (Units), 2015-2025 28

Figure 11: Orthobiologics Market, China, Company Share (%) 2017 33


List Of Table

1.1 List of Tables

Table 1: Orthobiologics Market, China, Revenue (USDm), USD Constant, 2015-2020 9

Table 2: Orthobiologics Market, China, Revenue (USDm), USD Constant, 2021-2025 9

Table 3: Bone Grafts and Substitutes Market, China, Revenue (USDm), USD Constant, 2015-2020 11

Table 4: Bone Grafts and Substitutes Market, China, Revenue (USDm), USD Constant, 2021-2025 11

Table 5: Bone Growth Stimulators Market, China, Revenue (USDm), USD Constant, 2015-2020 13

Table 6: Bone Growth Stimulators Market, China, Revenue (USDm), USD Constant, 2021-2025 13

Table 7: Soft Tissue Biologics Market, China, Revenue (USDm), USD Constant, 2015-2020 15

Table 8: Soft Tissue Biologics Market, China, Revenue (USDm), USD Constant, 2021-2025 15

Table 9: Viscosupplementation Market, China, Revenue (USDm), USD Constant, 2015-2020 17

Table 10: Viscosupplementation Market, China, Revenue (USDm), USD Constant, 2021-2025 17

Table 11: Orthobiologics Market, China, Volume (Units), 2015-2020 19

Table 12: Orthobiologics Market, China, Volume (Units), 2021-2025 20

Table 13: Bone Grafts and Substitutes Market, China, Volume (Units), 2015-2020 22

Table 14: Bone Grafts and Substitutes Market, China, Volume (Units), 2021-2025 23

Table 15: Bone Growth Stimulators Market, China, Volume (Units), 2015-2020 25

Table 16: Bone Growth Stimulators Market, China, Volume (Units), 2021-2025 25

Table 17: Soft Tissue Biologics Market, China, Volume (Units), 2015-2020 27

Table 18: Soft Tissue Biologics Market, China, Volume (Units), 2021-2025 27

Table 19: Viscosupplementation Market, China, Volume (Units), 2015-2020 29

Table 20: Viscosupplementation Market, China, Volume (Units), 2021-2025 29

Table 21: Orthobiologics Market, China, Average Price (USD), 2015-2020 30

Table 22: Orthobiologics Market, China, Average Price (USD), 2021-2025 31

Table 23: Orthobiologics Market, China, Distribution Share by Revenue (USDm), USD Constant, 2017 32

Table 24: Orthobiologics Market, China, Company Share by Revenue (USDm), USD Constant, 2017 34

Table 25: Orthobiologics Market Pipeline Products 37

Table 26: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 44

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag


Companies

Seikagaku Corp

DePuy Synthes Inc

Stryker Corp

Medtronic Plc

Zimmer Biomet Holdings Inc

IGEA SpA

ConMed Corporation

Shandong Haiyou Freda Pharmacy Co Ltd

China Orthobiologics Market Outlook to 2025

Summary

GlobalData's new report, China Orthobiologics Market Outlook to 2025, provides key market data on the China Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Orthobiologics market.

- Global corporate-level profiles of key companies operating within the China Orthobiologics market.

- Key players covered include Medtronic plc, Seikagaku Corp, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Orthobiologics Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Orthobiologics Market, China 7

3.1 Orthobiologics Market, China, Revenue (USDm), 2015-2025 7

3.2 Orthobiologics Market, China, Volume (Units), 2015-2025 17

3.3 Orthobiologics Market, China, Average Price (USD), 2015-2025 29

3.4 Orthobiologics Market, China, Distribution Share by Revenue (USDm), 2017 31

3.5 Orthobiologics Market, China, Company Share by Revenue (USDm), 2017 32

4 Overview of Key Companies in China, Orthobiologics Market 34

4.1 Seikagaku Corp 34

4.2 DePuy Synthes Inc 34

4.3 Stryker Corp 34

4.4 Medtronic Plc 34

4.5 Zimmer Biomet Holdings Inc 35

4.6 IGEA SpA 35

4.7 ConMed Corporation 35

4.8 Shandong Haiyou Freda Pharmacy Co Ltd 35

5 Orthobiologics Market Pipeline Products 36

6 Recent Developments 38

6.1 Corporate Communications 38

6.2 Financial Announcements 38

7 Appendix 40

7.1 Research Methodology 41

7.2 GlobalData Consulting 45

7.3 Contact Us 46

7.4 Disclaimer 46


List Of Figure

1.2 List of Figures

Figure 1: Orthobiologics Market, China, Revenue (USDm), USD Constant, 2015-2025 8

Figure 2: Bone Grafts and Substitutes Market, China, Revenue (USDm), USD Constant, 2015-2025 10

Figure 3: Bone Growth Stimulators Market, China, Revenue (USDm), USD Constant, 2015-2025 12

Figure 4: Soft Tissue Biologics Market, China, Revenue (USDm), USD Constant, 2015-2025 14

Figure 5: Viscosupplementation Market, China, Revenue (USDm), USD Constant, 2015-2025 16

Figure 6: Orthobiologics Market, China, Volume (Units), 2015-2025 18

Figure 7: Bone Grafts and Substitutes Market, China, Volume (Units), 2015-2025 21

Figure 8: Bone Growth Stimulators Market, China, Volume (Units), 2015-2025 24

Figure 9: Soft Tissue Biologics Market, China, Volume (Units), 2015-2025 26

Figure 10: Viscosupplementation Market, China, Volume (Units), 2015-2025 28

Figure 11: Orthobiologics Market, China, Company Share (%) 2017 33


List Of Table

1.1 List of Tables

Table 1: Orthobiologics Market, China, Revenue (USDm), USD Constant, 2015-2020 9

Table 2: Orthobiologics Market, China, Revenue (USDm), USD Constant, 2021-2025 9

Table 3: Bone Grafts and Substitutes Market, China, Revenue (USDm), USD Constant, 2015-2020 11

Table 4: Bone Grafts and Substitutes Market, China, Revenue (USDm), USD Constant, 2021-2025 11

Table 5: Bone Growth Stimulators Market, China, Revenue (USDm), USD Constant, 2015-2020 13

Table 6: Bone Growth Stimulators Market, China, Revenue (USDm), USD Constant, 2021-2025 13

Table 7: Soft Tissue Biologics Market, China, Revenue (USDm), USD Constant, 2015-2020 15

Table 8: Soft Tissue Biologics Market, China, Revenue (USDm), USD Constant, 2021-2025 15

Table 9: Viscosupplementation Market, China, Revenue (USDm), USD Constant, 2015-2020 17

Table 10: Viscosupplementation Market, China, Revenue (USDm), USD Constant, 2021-2025 17

Table 11: Orthobiologics Market, China, Volume (Units), 2015-2020 19

Table 12: Orthobiologics Market, China, Volume (Units), 2021-2025 20

Table 13: Bone Grafts and Substitutes Market, China, Volume (Units), 2015-2020 22

Table 14: Bone Grafts and Substitutes Market, China, Volume (Units), 2021-2025 23

Table 15: Bone Growth Stimulators Market, China, Volume (Units), 2015-2020 25

Table 16: Bone Growth Stimulators Market, China, Volume (Units), 2021-2025 25

Table 17: Soft Tissue Biologics Market, China, Volume (Units), 2015-2020 27

Table 18: Soft Tissue Biologics Market, China, Volume (Units), 2021-2025 27

Table 19: Viscosupplementation Market, China, Volume (Units), 2015-2020 29

Table 20: Viscosupplementation Market, China, Volume (Units), 2021-2025 29

Table 21: Orthobiologics Market, China, Average Price (USD), 2015-2020 30

Table 22: Orthobiologics Market, China, Average Price (USD), 2021-2025 31

Table 23: Orthobiologics Market, China, Distribution Share by Revenue (USDm), USD Constant, 2017 32

Table 24: Orthobiologics Market, China, Company Share by Revenue (USDm), USD Constant, 2017 34

Table 25: Orthobiologics Market Pipeline Products 37

Table 26: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag


Companies

Seikagaku Corp

DePuy Synthes Inc

Stryker Corp

Medtronic Plc

Zimmer Biomet Holdings Inc

IGEA SpA

ConMed Corporation

Shandong Haiyou Freda Pharmacy Co Ltd